1. Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future
   Mo-Yun Li et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
2. The Role of Pharmacogenomics in Drug-Induced Cardiovascular Toxicity
   Ranko Škrbić et al, 2024, Environmental Factors in the Pathogenesis of Cardiovascular Diseases CrossRef
3. Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity
   Xinyu Yang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
4. Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma
   Judit C. Sági et al, 2018, BMC Cancer CrossRef
5. Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
   Emma C. Bernsen et al, 2020, Frontiers in Pharmacology CrossRef
6. Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis
   Xinyu Yang et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
7. Drug-Related Carcinogenesis: Risk Factors and Approaches for Its Prevention
   G. A. Belitskiy et al, 2020, Biochemistry (Moscow) CrossRef
8. microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview
   Martino Marco Gabra et al, 2017, Frontiers in Oncology CrossRef
9. Understanding the role of genetics in childhood acute lymphoblastic leukemia (Review)
   Eleni Kampouraki et al, 2020, World Academy of Sciences Journal CrossRef
10. Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience
    Nicoletta Staropoli et al, 2024, Biomedicine & Pharmacotherapy CrossRef